benign%20prostatic%20hyperplasia
BENIGN PROSTATIC HYPERPLASIA
Benign prostatic hyperplasia (BPH) is a histopathological diagnosis characterized by epithelial cell & smooth muscle cell proliferation in the transition zone of the prostate leading to a non-malignant enlargement of the gland, which may result in lower urinary tract symptoms, including voiding and storage symptoms.
It is commonly called enlarged prostate.
Etiology is unknown but due to its similarity to the embryonic morphogenesis of the prostate has led to the hypothesis that BPH may be the result of "reawakening" in adulthood of embryonic induction processes.

Benign Prostatic Hyperplasia Drug Information

Drug Information

Indication: Functional symptoms of benign prostatic hyperplasia (BPH).

Indication: HTN. Symptomatic relief of benign prostatic hyperplasia (BPH).

Indication: Bladder outlet obstruction associated w/ BPH in patients ≥50 yr.

Indication: Monotherapy or in combination w/ tamsulosin for treatment & control of symptomatic benign prostatic hyperp...

Indication: HTN & initial agent to control BP. In hypertensive or normotensive patients w/ benign prostatic hyperplasi...

Indication: Erectile dysfunction. 5 mg: Symptomatic treatment of benign prostatic hyperplasia (BPH).

Indication: Symptomatic benign prostatic hyperplasia (BPH). HTN.

Indication: Moderate to severe benign prostatic hyperplasia (BPH) symptoms; reduces risk of acute urinary retention & ...

Indication: HTN. Improve clinical symptoms & increase urine flow in benign prostatic hyperplasia.

Indication: HTN & benign prostatic hyperplasia (BPH).

1  /  2
Editor's Recommendations
Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 3 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.